Motif ID	Motif Logo	Scanned Score Distribution	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_h9_promoter_n_PM_12_26_8			1	0.25	2.18E-04	DNA2, SYTL4	gamma DNA polymerase complex [CC], synaptic vesicle [CC]
CG_h9_promoter_n_PM_12_190_10			2	0.5	9.14E-05	RTP2	olfactory receptor binding [MF]
CG_h9_promoter_n_PM_16_46_52			2	0.5	3.28E-05	INPP5K, IMPA1, MYO5B, DNAAF2, DNAAF3, AQP7	inositol phosphate dephosphorylation [BP], water transport [BP], axonemal dynein complex assembly [BP]
CG_h9_promoter_n_PM_12_257_4			1	0.25	1.38E-04	PABPC1	negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [BP]
CG_h9_promoter_n_PM_14_22_5			2	0.5	1.74E-05	CTC1, CD14, CD74	opsonin receptor activity [MF], NOS2-CD74 complex [CC], macrophage migration inhibitory factor signaling pathway [BP], macrophage migration inhibitory factor binding [MF], Stn1-Ten1 complex [CC], macrophage migration inhibitory factor receptor complex [CC]
CG_h9_promoter_n_PM_12_266_11			1	0.25	2.57E-04	GALNT18	protein glycosylation [BP]
CG_h9_promoter_n_PM_12_286_5			2	0.25	1.13E-04	GALNS	N-acetylgalactosamine-6-sulfatase activity [MF]
CG_h9_promoter_n_PM_14_4_4			1	0.25	9.86E-05	COQ3	2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [MF], 3-demethylubiquinone-9 3-O-methyltransferase activity [MF], hexaprenyldihydroxybenzoate methyltransferase activity [MF]
CG_h9_promoter_n_PM_12_93_9			2	0.5	3.49E-04	CTC1	Stn1-Ten1 complex [CC]
CG_h9_promoter_n_PM_12_135_10			1	0.25	1.09E-04	ALOX15	arachidonate 15-lipoxygenase activity [MF]
CG_h9_promoter_n_PM_12_128_9			2	0.5	2.51E-04	LATS1	sister chromatid segregation [BP]
CG_h9_promoter_n_PM_12_243_6			1	0.25	2.78E-05	CACTIN, GNB1, HPS1	negative regulation of type I interferon-mediated signaling pathway [BP], retina development in camera-type eye [BP]
CG_h9_promoter_n_PM_14_29_13			2	0.5	4.11E-05	TRMT2B, BCAT2	S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [MF], isoleucine catabolic process [BP]
CG_h9_promoter_n_PM_14_6_20			3	0.75	3.52E-05	UFSP1	UFM1 hydrolase activity [MF]
CG_h9_promoter_n_PM_12_168_12			1	0.25	7.01E-05	MMS19, SULF2	esophagus smooth muscle contraction [BP], phosphorelay signal transduction system [BP]
CG_h9_promoter_n_PM_12_133_9			1	0.25	7.74E-06	PITPNA	stearic acid binding [MF]
CG_h9_promoter_n_PM_12_316_7			2	0.5	1.22E-04	CHORDC1	negative regulation of Rho-dependent protein serine/threonine kinase activity [BP]
CG_h9_promoter_n_PM_12_101_8			1	0.25	1.32E-04	OCSTAMP	positive regulation of osteoclast proliferation [BP]
CG_h9_promoter_n_PM_12_69_7			1	0.25	3.27E-05	DYNLT1, TRIM11	negative regulation of neurogenesis [BP]
CG_h9_promoter_n_PM_12_326_11			2	0.5	8.18E-05	DCAKD, SHARPIN, SLC33A1, SREBF1	sterol response element binding [MF], regulation of CD40 signaling pathway [BP], acetyl-CoA transporter activity [MF], dephospho-CoA kinase activity [MF], acetyl-CoA transport [BP]
CG_h9_promoter_n_PM_14_26_10			1	0.25	1.20E-04	ACOT8, RACGAP1	medium-chain acyl-CoA hydrolase activity [MF], choloyl-CoA hydrolase activity [MF], cytokinesis, actomyosin contractile ring assembly [BP], cytokinesis, initiation of separation [BP]
CG_h9_promoter_n_PM_14_76_15			2	0.5	5.25E-05	PRICKLE1, NODAL, SPAG5, CUL3, MYOF, TMED10, TOR1AIP2	COPII vesicle coating [BP], mitotic anaphase [BP], anaphase [BP], nuclear membrane [CC], trophectodermal cellular morphogenesis [BP]
CG_h9_promoter_n_PM_12_164_11			2	0.25	7.10E-05	TMEM86B, NTF4	sensory organ boundary specification [BP], alkenylglycerophosphocholine hydrolase activity [MF], alkenylglycerophosphoethanolamine hydrolase activity [MF]
CG_h9_promoter_n_PM_16_33_21			1	0.25	4.63E-05	SYNE4, NCOR1, MEX3D	integral to nuclear outer membrane [CC], mRNA localization resulting in posttranscriptional regulation of gene expression [BP], regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter [BP]
CG_h9_promoter_n_PM_12_335_10			2	0.5	2.59E-04	PSME2, CCBL2, PSMC3	proteasome accessory complex [CC], antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [BP], S phase of mitotic cell cycle [BP], cysteine-S-conjugate beta-lyase activity [MF], cellular amino acid metabolic process [BP], kynurenine-glyoxylate transaminase activity [MF], M/G1 transition of mitotic cell cycle [BP], antigen processing and presentation of peptide antigen via MHC class I [BP], regulation of cellular amino acid metabolic process [BP], proteasome activator complex [CC], antigen processing and presentation of exogenous peptide antigen via MHC class I [BP], proteasome complex [CC], positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [BP], DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [BP], anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process [BP], negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [BP], regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [BP]
CG_h9_promoter_n_PM_12_234_9			2	0.5	1.47E-04	CYBA	smooth muscle hypertrophy [BP], negative regulation of glomerular filtration by angiotensin [BP]
CG_h9_promoter_n_PM_14_32_20			2	0.5	1.02E-05	STAR	cellular response to luteinizing hormone stimulus [BP], insecticide metabolic process [BP]
CG_h9_promoter_n_PM_12_43_5			2	0.5	8.92E-05	PRHOXNB, SLC16A1	mevalonate transport [BP], mevalonate transmembrane transporter activity [MF], urate catabolic process [BP], allantoin biosynthetic process [BP]
CG_h9_promoter_n_PM_12_55_7			2	0.5	1.14E-04	PPT1	protein depalmitoylation [BP], positive regulation of pinocytosis [BP]
CG_h9_promoter_n_PM_12_350_13			2	0.5	9.81E-05	CPLX1	synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [CC]
CG_h9_promoter_n_PM_12_154_10			2	0.5	1.29E-04	NECAB3, APOBEC1	Golgi cis cisterna [CC], cytidine to uridine editing [BP], negative regulation of methylation-dependent chromatin silencing [BP]
CG_h9_promoter_n_PM_12_293_6			1	0.25	1.06E-04	PIGU, C3	C5L2 anaphylatoxin chemotactic receptor binding [MF], regulation of JAK-STAT cascade [BP]
CG_h9_promoter_n_PM_12_191_6			1	0.25	1.46E-04	SOD2, AXIN1, UROS, IL12RB1	cellular response to amine stimulus [BP], uroporphyrinogen-III synthase activity [MF], interleukin-12 receptor complex [CC], vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [BP], erythrophore differentiation [BP], interleukin-12 receptor activity [MF], age-dependent response to reactive oxygen species [BP], negative regulation of fat cell differentiation [BP]
CG_h9_promoter_n_PM_12_344_5			2	0.5	6.08E-05	ANXA5, BCL11B, SUN2	endothelial microparticle [CC], striatal medium spiny neuron differentiation [BP], nuclear migration along microfilament [BP], olfactory bulb axon guidance [BP]
CG_h9_promoter_n_PM_12_289_9			1	0.25	2.30E-04	GADL1	carboxy-lyase activity [MF]
CG_h9_promoter_n_PM_12_309_8			3	0.5	2.75E-05	APP, OPCML	neuron recognition [BP], smooth endoplasmic reticulum calcium ion homeostasis [BP], PTB domain binding [MF]
CG_h9_promoter_n_PM_12_99_9			1	0.25	3.71E-05	HAND1, UNC13A, MYH10	embryonic heart tube formation [BP], neuromuscular junction [CC]
CG_h9_promoter_n_PM_14_2_34			4	0.75	5.07E-05	RHOA, NFKBID, TLE1	negative regulation of I-kappaB kinase/NF-kappaB cascade [BP]
CG_h9_promoter_n_PM_14_36_18			4	0.5	4.77E-05	CCL26, HRAS	positive regulation of Rac GTPase activity [BP]
CG_h9_promoter_n_PM_12_105_8			2	0.5	1.33E-04	MAP4	microtubule sliding [BP]
CG_h9_promoter_n_PM_12_127_17			1	0.25	2.26E-04	MEN1, MFNG	positive regulation of protein binding [BP]
CG_h9_promoter_n_PM_14_35_5			4	0.5	5.14E-05	TK2, KDM2B	initiation of neural tube closure [BP], deoxycytidine metabolic process [BP]
CG_h9_promoter_n_PM_12_292_13			3	0.5	2.55E-04	KLHL21, ADPRHL1, MAP3K11	polar microtubule [CC], protein de-ADP-ribosylation [BP], ADP-ribosylarginine hydrolase activity [MF], JUN kinase kinase kinase activity [MF]
CG_h9_promoter_n_PM_12_10_7			1	0.25	1.15E-04	ARFGEF1, ENTPD4	positive regulation of protein glycosylation in Golgi [BP], UDP catabolic process [BP]
CG_h9_promoter_n_PM_12_137_15			2	0.5	2.14E-05	GPLD1, SHPK, GTF2E2	negative regulation of triglyceride catabolic process [BP], complement receptor mediated signaling pathway [BP], GPI anchor release [BP], cellular response to triglyceride [BP], sedoheptulokinase activity [MF], positive regulation of high-density lipoprotein particle clearance [BP], glycosylphosphatidylinositol phospholipase D activity [MF], cellular response to interleukin-13 [BP], hematopoietic stem cell migration to bone marrow [BP], transcription factor TFIIE complex [CC]
CG_h9_promoter_n_PM_14_69_12			2	0.5	3.84E-05	PMCH	melanin-concentrating hormone activity [MF]
CG_h9_promoter_n_PM_12_13_10			2	0.5	4.28E-05	WNT4	negative regulation of testosterone biosynthetic process [BP], positive regulation of cortisol biosynthetic process [BP], negative regulation of testicular blood vessel morphogenesis [BP], negative regulation of male gonad development [BP]
CG_h9_promoter_n_PM_12_170_17			3	0.5	8.89E-05	PDE2A, UCP3	mitochondrial transport [BP], establishment of endothelial barrier [BP]
CG_h9_promoter_n_PM_12_237_9			1	0.25	1.02E-04	HDDC3, SLC22A6, NOP14, CYP4F2, TACR2, KLK14	Noc4p-Nop14p complex [CC], prolactin secretion [BP], renal tubular secretion [BP], guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF], tocotrienol omega-hydroxylase activity [MF], substance K receptor activity [MF], seminal clot liquefaction [BP]
CG_h9_promoter_n_PM_12_120_8			1	0.25	1.27E-04	MESP1, EGLN1, PLOD2, CYP2C8, TGFBR3	negative regulation of endodermal cell fate specification [BP], positive regulation of Notch signaling pathway involved in heart induction [BP], cardiac atrium formation [BP], heart morphogenesis [BP], cardioblast migration to the midline involved in heart field formation [BP], cardioblast anterior-lateral migration [BP], heart trabecula formation [BP], L-ascorbic acid binding [MF], sinus venosus morphogenesis [BP], iron ion binding [MF]
CG_h9_promoter_n_PM_12_134_9			2	0.25	2.34E-04	PDGFA	regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP]
CG_h9_promoter_n_PM_16_9_18			1	0.25	3.29E-05	CYP11A1, CRNKL1, HTR2B, SNRNP40	cellular response to temperature stimulus [BP], cholesterol monooxygenase (side-chain-cleaving) activity [MF], catalytic step 2 spliceosome [CC], response to genistein [BP]
CG_h9_promoter_n_PM_12_107_7			4	0.5	1.06E-04	NOP14	Noc4p-Nop14p complex [CC]
CG_h9_promoter_n_PM_16_44_7			1	0.25	9.57E-05	AGXT2L1	ethanolamine-phosphate phospho-lyase activity [MF]
CG_h9_promoter_n_PM_12_332_9			2	0.5	2.59E-04	SHH	CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [BP], intein-mediated protein splicing [BP], right lung development [BP], mesenchymal smoothened signaling pathway involved in prostate gland development [BP], regulation of mesenchymal cell proliferation involved in prostate gland development [BP], positive regulation of skeletal muscle cell proliferation [BP], negative regulation of kidney smooth muscle cell differentiation [BP], positive regulation of epithelial cell proliferation involved in prostate gland development [BP], primary prostatic bud elongation [BP], negative regulation of ureter smooth muscle cell differentiation [BP], epithelial-mesenchymal signaling involved in prostate gland development [BP], positive regulation of kidney smooth muscle cell differentiation [BP], positive regulation of ureter smooth muscle cell differentiation [BP], positive regulation of sclerotome development [BP], multicellular structure septum development [BP]
CG_h9_promoter_n_PM_12_245_11			1	0.25	1.11E-04	CCND3, MAK	cyclin-dependent protein kinase activity [MF]
CG_h9_promoter_n_PM_12_118_17			2	0.5	1.47E-04	S100B, RBM22	calcium-dependent protein binding [MF]
CG_h9_promoter_n_PM_12_58_11			1	0.25	1.17E-04	BRCA1	positive regulation of histone H4-K20 methylation [BP], positive regulation of histone H3-K9 acetylation [BP], positive regulation of histone H4-K16 acetylation [BP]
CG_h9_promoter_n_PM_12_319_9			2	0.5	2.59E-04	CTRL, PYY	digestion [BP]
CG_h9_promoter_n_PM_12_140_10			2	0.5	7.41E-05	CBS	cysteine biosynthetic process via cystathionine [BP], cystathionine beta-synthase activity [MF], cysteine biosynthetic process from serine [BP], homocysteine catabolic process [BP]
CG_h9_promoter_n_PM_12_126_7			1	0.25	9.80E-04	ZNF260, ZFP14, ZNF780B, ZNF607, ZNF781	transcription, DNA-dependent [BP], DNA binding [MF], regulation of transcription, DNA-dependent [BP], zinc ion binding [MF]
CG_h9_promoter_n_PM_12_210_16			2	0.5	1.18E-04	GHRL, NUDT18	GDP catabolic process [BP], 8-oxo-dGDP phosphatase activity [MF], 8-hydroxy-dADP phosphatase activity [MF], positive regulation of cortisol secretion [BP], 8-oxo-GDP phosphatase activity [MF], positive regulation of appetite [BP], cortisol secretion [BP], positive regulation of growth hormone receptor signaling pathway [BP], ghrelin receptor binding [MF], negative regulation of circadian sleep/wake cycle, REM sleep [BP], dADP catabolic process [BP], positive regulation of circadian sleep/wake cycle, non-REM sleep [BP], dGDP catabolic process [BP], growth hormone-releasing hormone activity [MF]
CG_h9_promoter_n_PM_12_249_7			2	0.5	1.43E-04	PELI1, NTAN1, MAP3K7, IRS1, DCX, STK38, PTK2	phosphatidylinositol 3-kinase binding [MF], positive regulation of phosphatidylinositol 3-kinase activity [BP], intracellular signal transduction [BP], growth hormone receptor signaling pathway [BP], SH2 domain binding [MF], protein-N-terminal asparagine amidohydrolase activity [MF], toll-like receptor 1 signaling pathway [BP], netrin-activated signaling pathway [BP], central nervous system neuron axonogenesis [BP], intracellular protein kinase cascade [BP], protein kinase binding [MF]
CG_h9_promoter_n_PM_12_180_6			1	0.25	7.25E-05	DAB1	cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration [BP]
CG_h9_promoter_n_PM_12_239_5			1	0.25	1.79E-04	NDUFAB1	ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process [MF]
CG_h9_promoter_n_PM_12_315_11			3	0.5	2.22E-05	ENPP2, PRICKLE1	alkylglycerophosphoethanolamine phosphodiesterase activity [MF], negative regulation of cardiac muscle cell myoblast differentiation [BP]
CG_h9_promoter_n_PM_12_247_8			1	0.25	7.79E-05	WIPI1, TOP1MT, DDX54, POLDIP2	estrogen receptor binding [MF], mitochondrial nucleoid [CC]
CG_h9_promoter_n_PM_12_274_8			1	0.25	5.21E-05	NAGPA, DHH, SHH	metanephric mesenchymal cell proliferation involved in metanephros development [BP], regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [BP], negative regulation of ureter smooth muscle cell differentiation [BP], right lung development [BP], positive regulation of immature T cell proliferation in thymus [BP], N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity [MF], negative regulation of cholesterol efflux [BP], multicellular structure septum development [BP], epithelial-mesenchymal signaling involved in prostate gland development [BP], positive regulation of kidney smooth muscle cell differentiation [BP], CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [BP], intein-mediated protein splicing [BP], left lung development [BP], positive regulation of mesenchymal cell proliferation involved in ureter development [BP], positive regulation of skeletal muscle cell proliferation [BP], negative regulation of kidney smooth muscle cell differentiation [BP], positive regulation of epithelial cell proliferation involved in prostate gland development [BP], primary prostatic bud elongation [BP], patched binding [MF], mesenchymal cell proliferation involved in lung development [BP], bud outgrowth involved in lung branching [BP], smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [BP], Bergmann glial cell differentiation [BP], mesenchymal smoothened signaling pathway involved in prostate gland development [BP], prostate epithelial cord elongation [BP], regulation of mesenchymal cell proliferation involved in prostate gland development [BP], positive regulation of hh target transcription factor activity [BP], positive regulation of ureter smooth muscle cell differentiation [BP], positive regulation of sclerotome development [BP]
CG_h9_promoter_n_PM_12_8_9			1	0.25	1.22E-04	UBE3A, SEPSECS, PLAC1	sperm entry [BP], transferase activity, transferring selenium-containing groups [MF], spongiotrophoblast layer developmental growth [BP]
CG_h9_promoter_n_PM_16_39_19			3	0.75	2.76E-05	CCL3, SMARCC1, RPS16, SUPT16H	viral transcription [BP], positive regulation of gene expression [BP], nucleosome disassembly [BP]
CG_h9_promoter_n_PM_12_103_7			1	0.25	9.66E-05	ST8SIA5, AP3B2, LAPTM4A, YIF1A, LARGE	glycosphingolipid biosynthetic process [BP], Golgi apparatus [CC]
CG_h9_promoter_n_PM_12_265_13			1	0.25	1.05E-04	NRP1, SEMA4C	semaphorin-plexin signaling pathway [BP]
CG_h9_promoter_n_PM_12_49_8			3	0.5	6.94E-05	ALDH1L1, NFS1	oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [MF], cysteine metabolic process [BP]
CG_h9_promoter_n_PM_14_48_23			2	0.5	7.49E-05	VDR, A4GALT	lactosylceramide 4-alpha-galactosyltransferase activity [MF], vitamin D3 receptor activity [MF]
CG_h9_promoter_n_PM_12_54_13			2	0.5	5.83E-05	NFIB	negative regulation of mesenchymal cell proliferation involved in lung development [BP], negative regulation of epithelial cell proliferation involved in lung morphogenesis [BP]
CG_h9_promoter_n_PM_16_49_16			1	0.25	3.47E-05	STAT3, FOXO1	temperature homeostasis [BP]
CG_h9_promoter_n_PM_12_208_9			1	0.25	2.07E-05	GPLD1, SDC1	GPI anchor release [BP], cellular response to triglyceride [BP], response to calcium ion [BP], glycosylphosphatidylinositol phospholipase D activity [MF]
CG_h9_promoter_n_PM_12_268_8			1	0.25	1.11E-04	MEF2C	sinoatrial valve morphogenesis [BP], regulation of synaptic activity [BP], cellular response to trichostatin A [BP], primary heart field specification [BP]
CG_h9_promoter_n_PM_12_187_12			2	0.5	4.52E-05	EEF1G, XRCC2, LGMN, RPL22, RPS13	translational elongation [BP], translational termination [BP], negative regulation of neuron apoptotic process [BP]
CG_h9_promoter_n_PM_12_138_19			2	0.5	4.57E-05	SLC25A1	mitochondrial citrate transport [BP]
CG_h9_promoter_n_PM_12_279_4			1	0.25	1.10E-04	TDP2, DHCR24, MAFB	5'-tyrosyl-DNA phosphodiesterase activity [MF], rhombomere 6 development [BP], delta24-sterol reductase activity [MF], tyrosyl-RNA phosphodiesterase activity [MF]
CG_h9_promoter_n_PM_12_12_8			2	0.5	1.23E-04	CBX4, LOXL2	methylated histone residue binding [MF]
CG_h9_promoter_n_PM_12_246_11			2	0.5	2.86E-05	NAGPA	N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity [MF]
CG_h9_promoter_n_PM_12_291_10			2	0.5	5.18E-05	ZNF750	core promoter sequence-specific DNA binding [MF]
CG_h9_promoter_n_PM_12_102_13			1	0.25	1.23E-04	AIPL1, PTPN22	phosphoanandamide dephosphorylation [BP], farnesylated protein binding [MF]
CG_h9_promoter_n_PM_12_119_6			1	0.25	9.75E-05	CHM	Rab-protein geranylgeranyltransferase complex [CC]
CG_h9_promoter_n_PM_12_20_11			5	0.75	5.95E-05	IRF6	keratinocyte proliferation [BP]
CG_h9_promoter_n_PM_12_323_9			2	0.5	7.31E-05	SLC27A5	cholate-CoA ligase activity [MF]
CG_h9_promoter_n_PM_14_5_5			1	0.25	4.34E-05	NFS1	cysteine desulfurase activity [MF]
CG_h9_promoter_n_PM_12_156_5			1	0.25	6.47E-05	ATG5, CCDC39	otolith development [BP], epithelial cilium movement involved in determination of left/right asymmetry [BP], negative regulation of protein ubiquitination [BP], flagellar cell motility [BP]
CG_h9_promoter_n_PM_12_294_7			2	0.25	8.46E-05	PAXIP1, LYST	neutrophil mediated immunity [BP], positive regulation of histone H3-K36 methylation [BP]
CG_h9_promoter_n_PM_12_130_8			1	0.25	1.38E-04	STRA6, HBEGF	alveolar primary septum development [BP], negative regulation of elastin biosynthetic process [BP], vitamin A import [BP]
CG_h9_promoter_n_PM_12_225_8			1	0.25	9.31E-05	BRD4	regulation of transcription involved in G1 phase of mitotic cell cycle [BP]
CG_h9_promoter_n_PM_12_60_9			2	0.25	6.50E-05	SLC35B4, UXS1, MSTN	negative regulation of skeletal muscle tissue growth [BP], UDP-xylose transport [BP], UDP-D-xylose biosynthetic process [BP], UDP-glucuronate decarboxylase activity [MF], UDP-xylose transmembrane transporter activity [MF]
CG_h9_promoter_n_PM_12_229_4			1	0.25	2.49E-05	DNMT3A	S-adenosylhomocysteine metabolic process [BP], DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates [MF]
CG_h9_promoter_n_PM_16_2_29			4	0.75	8.76E-05	PRCP, VWF	blood coagulation, intrinsic pathway [BP]
CG_h9_promoter_n_PM_14_58_11			1	0.25	5.56E-05	BST2	negative regulation of egress of virus within host cell [BP], negative regulation of plasmacytoid dendritic cell cytokine production [BP]
CG_h9_promoter_n_PM_12_39_12			1	0.25	3.28E-05	CLASP1, DNPH1	nucleoside deoxyribosyltransferase activity [MF], deoxyribonucleoside 5'-monophosphate N-glycosidase activity [MF], centrosomal corona [CC]
CG_h9_promoter_n_PM_12_325_6			2	0.5	7.02E-06	BST2	negative regulation of egress of virus within host cell [BP], negative regulation of plasmacytoid dendritic cell cytokine production [BP]
CG_h9_promoter_n_PM_12_186_4			1	0.25	1.04E-05	PECR	phytol metabolic process [BP], trans-2-enoyl-CoA reductase (NADPH) activity [MF]
CG_h9_promoter_n_PM_12_167_12			2	0.25	1.91E-04	TNFRSF18, TRADD	tumor necrosis factor-mediated signaling pathway [BP]
CG_h9_promoter_n_PM_14_41_7			1	0.25	5.56E-05	HMGN1, KLF4	positive regulation of DNA-dependent transcription, elongation [BP], post-embryonic camera-type eye development [BP]
CG_h9_promoter_n_PM_12_47_5			2	0.5	7.09E-05	MAP4, TNC	microtubule sliding [BP], mesenchymal-epithelial cell signaling involved in prostate gland development [BP]
CG_h9_promoter_n_PM_12_311_9			1	0.25	7.60E-06	PLTP, UBE2V1	UBC13-UEV1A complex [CC], vitamin E biosynthetic process [BP]
CG_h9_promoter_n_PM_12_32_7			2	0.5	1.56E-04	TK2, ANGPT2	negative regulation of positive chemotaxis [BP], deoxycytidine metabolic process [BP]
CG_h9_promoter_n_PM_12_67_10			1	0.25	1.81E-04	NHP2	rRNA pseudouridine synthesis [BP]
CG_h9_promoter_n_PM_12_328_16			2	0.5	1.77E-05	ADAM8, BAZ1B	vitamin D receptor activator activity [MF], positive regulation of neutrophil extravasation [BP], positive regulation of fibronectin-dependent thymocyte migration [BP], dense core granule membrane [CC], alpha9-beta1 integrin-ADAM8 complex [CC], positive regulation of eosinophil migration [BP], DNA replication-dependent nucleosome disassembly [BP]
CG_h9_promoter_n_PM_14_59_8			6	1.0	4.16E-05	TNPO3	splicing factor protein import into nucleus [BP]
CG_h9_promoter_n_PM_12_189_5			1	0.25	1.48E-04	SLC35B2, SLC29A2, CYP39A1, THEM5	steroid 7-alpha-hydroxylase activity [MF], long-chain fatty-acyl-CoA metabolic process [BP], nucleoside transmembrane transporter activity [MF], 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [MF], nucleoside transport [BP], 24-hydroxycholesterol 7alpha-hydroxylase activity [MF]
CG_h9_promoter_n_PM_12_238_7			2	0.5	4.55E-05	ST6GALNAC6, CELSR1, B4GALT1	protein localization involved in establishment of planar polarity [BP], cell-cell recognition [BP], oligosaccharide biosynthetic process [BP]
CG_h9_promoter_n_PM_14_23_13			1	0.25	6.87E-05	GSR, EPHA2, DAPK2, EDNRB	notochord cell development [BP], enteric smooth muscle cell differentiation [BP], autophagic vacuole lumen [CC], endothelin receptor signaling pathway [BP], glutathione-disulfide reductase activity [MF]
CG_h9_promoter_n_PM_12_211_6			2	0.25	7.60E-05	TNC	mesenchymal-epithelial cell signaling involved in prostate gland development [BP]
CG_h9_promoter_n_PM_14_83_8			1	0.25	4.00E-05	NLRC4	interleukin-1 beta secretion [BP]
CG_h9_promoter_n_PM_12_331_9			1	0.25	5.47E-05	SLC15A1	proton-dependent oligopeptide secondary active transmembrane transporter activity [MF], peptide:hydrogen symporter activity [MF]
CG_h9_promoter_n_PM_12_98_5			2	0.5	6.98E-05	ATG5, VPS28	negative regulation of protein ubiquitination [BP]
CG_h9_promoter_n_PM_12_193_20			2	0.25	4.82E-05	SPIRE1	intracellular transport [BP]
CG_h9_promoter_n_PM_12_110_7			4	0.5	1.58E-04	NEDD4	negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [BP], transmission of virus [BP], development involved in symbiotic interaction [BP]
CG_h9_promoter_n_PM_14_3_25			6	1.0	4.63E-05	CHD4, AHCTF1, WNT3, CDC25A, CLSPN, MCM7, CSNK1E, GAK, SEPT8, HTR2B, DCTN2, MTNR1A, NPPC, FZD4	positive regulation of cGMP biosynthetic process [BP], cell cycle [BP], cGMP biosynthetic process [BP], Wnt receptor signaling pathway, calcium modulating pathway [BP], ATP-dependent DNA helicase activity [MF], mitotic cell cycle [BP]
CG_h9_promoter_n_PM_12_175_5			1	0.25	1.06E-04	TTC21B, KIF3A, CTSL2	cilium morphogenesis [BP], kininogen binding [MF], kinesin II complex [CC], smoothened signaling pathway [BP], antigen processing and presentation of exogenous peptide antigen via MHC class II [BP]
CG_h9_promoter_n_PM_12_248_11			1	0.25	5.05E-05	CLTB, MESP1	clathrin coat of coated pit [CC], negative regulation of endodermal cell fate specification [BP], positive regulation of Notch signaling pathway involved in heart induction [BP], cardiac atrium formation [BP], clathrin coat [CC], cardioblast migration to the midline involved in heart field formation [BP], cardioblast anterior-lateral migration [BP], sinus venosus morphogenesis [BP]
CG_h9_promoter_n_PM_12_81_12			2	0.5	5.99E-05	RAB3A	maintenance of presynaptic active zone structure [BP]
CG_h9_promoter_n_PM_16_1_59			4	0.75	5.84E-05	AVP, GRB2, ABCB10, TRPV4, ABCB9, TNK2	Grb2-EGFR complex [CC], hyperosmotic salinity response [BP], oligopeptide-transporting ATPase activity [MF]
CG_h9_promoter_n_PM_12_177_8			1	0.25	2.64E-04	DDX58, CARS2	cysteinyl-tRNA aminoacylation [BP], detection of virus [BP], regulation of type III interferon production [BP], cysteine-tRNA ligase activity [MF]
CG_h9_promoter_n_PM_12_217_12			1	0.25	2.25E-05	SLU7	pre-mRNA 3'-splice site binding [MF], second spliceosomal transesterification activity [MF]
CG_h9_promoter_n_PM_12_149_8			1	0.25	1.44E-04	TRPV3, CBS	negative regulation of hair cycle [BP], cysteine biosynthetic process via cystathionine [BP], cystathionine beta-synthase activity [MF], cysteine biosynthetic process from serine [BP], homocysteine catabolic process [BP]
CG_h9_promoter_n_PM_12_281_13			3	0.75	2.12E-04	GRPEL1	adenyl-nucleotide exchange factor activity [MF]
CG_h9_promoter_n_PM_12_106_8			2	0.5	2.74E-05	RELA, SEPHS2	acetaldehyde metabolic process [BP], selenocysteine biosynthetic process [BP]
CG_h9_promoter_n_PM_12_82_7			1	0.25	5.38E-05	POP5, AARS	tRNA processing [BP]
CG_h9_promoter_n_PM_12_59_12			3	0.75	4.64E-04	KRT9, KRT14, KRT16	cytoskeleton organization [BP], intermediate filament cytoskeleton organization [BP], structural constituent of cytoskeleton [MF], intermediate filament [CC], intermediate filament organization [BP], epidermis development [BP]
CG_h9_promoter_n_PM_12_116_6			1	0.25	4.95E-04	SHARPIN	regulation of CD40 signaling pathway [BP], LUBAC complex [CC]
CG_h9_promoter_n_PM_12_340_4			1	0.25	2.66E-05	TYW5, HPSE	wybutosine biosynthetic process [BP], glycosaminoglycan catabolic process [BP]
CG_h9_promoter_n_PM_16_10_18			1	0.25	4.45E-05	PIF1	single-stranded DNA-dependent ATP-dependent DNA helicase activity [MF], ATP-dependent 5'-3' DNA/RNA helicase activity [MF]
CG_h9_promoter_n_PM_12_182_12			1	0.25	5.47E-05	SLCO2A1, TMEM173, NCOR2	cyclic-di-GMP binding [MF], prostaglandin transmembrane transporter activity [MF], regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter [BP]
CG_h9_promoter_n_PM_12_132_12			2	0.25	1.10E-04	NOTCH1	inflammatory response to antigenic stimulus [BP]
CG_h9_promoter_n_PM_12_215_8			2	0.5	5.93E-05	MTHFR	methylenetetrahydrofolate reductase (NADPH) activity [MF]
CG_h9_promoter_n_PM_14_55_14			2	0.5	4.66E-05	IL13RA2, CACTIN, COL7A1, PDF, NFS1	cytokine-mediated signaling pathway [BP], collagen type VII [CC], cysteine desulfurase activity [MF], peptide deformylase activity [MF], cellular response to interleukin-1 [BP]
CG_h9_promoter_n_PM_12_300_10			1	0.25	1.03E-04	CYP11A1, FOXL2, PHLDA3, MYO10, PITPNA	cholesterol monooxygenase (side-chain-cleaving) activity [MF], female somatic sex determination [BP], phosphatidylinositol-3,4,5-trisphosphate binding [MF], phosphatidylinositol binding [MF], menstruation [BP], stearic acid binding [MF], granulosa cell differentiation [BP], response to genistein [BP]
CG_h9_promoter_n_PM_12_333_5			2	0.5	3.42E-05	IL9, TMEM86B	positive regulation of interleukin-5 biosynthetic process [BP], alkenylglycerophosphocholine hydrolase activity [MF], interleukin-9 receptor binding [MF], alkenylglycerophosphoethanolamine hydrolase activity [MF]
CG_h9_promoter_n_PM_12_227_9			1	0.25	1.19E-05	DRD2, PRLR	auditory behavior [BP], response to histamine [BP], negative regulation of dopamine receptor signaling pathway [BP], prolactin signaling pathway [BP], reduction of cytosolic calcium ion concentration [BP], negative regulation of circadian sleep/wake cycle, sleep [BP], ornithine decarboxylase activator activity [MF], positive regulation of dopamine uptake involved in synaptic transmission [BP], prolactin receptor activity [MF], activation of protein kinase activity [BP], adenylate cyclase-inhibiting dopamine receptor signaling pathway [BP], dopamine neurotransmitter receptor activity, coupled via Gi/Go [MF], cerebral cortex GABAergic interneuron migration [BP], negative regulation of voltage-gated calcium channel activity [BP], response to inactivity [BP], behavioral response to ethanol [BP], branching morphogenesis of a nerve [BP], regulation of dopamine uptake involved in synaptic transmission [BP]
CG_h9_promoter_n_PM_12_260_15			2	0.5	7.19E-05	GSS, NOS2, COL4A1, NOA1, PDGFA	platelet-derived growth factor binding [MF], response to amino acid stimulus [BP], regulation of cellular respiration [BP]
CG_h9_promoter_n_PM_12_337_10			2	0.5	8.37E-05	LIFR, LALBA	lactose biosynthetic process [BP], leukemia inhibitory factor receptor activity [MF]
CG_h9_promoter_n_PM_12_100_7			1	0.25	1.31E-04	FOXL2, PXN, FECH, BARD1, PMVK	detection of UV [BP], ferrochelatase activity [MF], BH4 domain binding [MF], female somatic sex determination [BP], phosphomevalonate kinase activity [MF], negative regulation of mRNA 3'-end processing [BP], menstruation [BP]
CG_h9_promoter_n_PM_12_355_5			1	0.25	2.25E-04	PAXIP1	positive regulation of histone H3-K36 methylation [BP]
CG_h9_promoter_n_PM_16_14_33			2	0.5	6.63E-06	B3GNT8	poly-N-acetyllactosamine biosynthetic process [BP]
CG_h9_promoter_n_PM_16_11_21			3	0.5	3.00E-05	ABO, TRIT1	fucosylgalactoside 3-alpha-galactosyltransferase activity [MF], glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity [MF], tRNA dimethylallyltransferase activity [MF]
CG_h9_promoter_n_PM_12_96_8			2	0.5	3.79E-05	PHB, PRLR	prolactin signaling pathway [BP], prolactin receptor activity [MF], negative regulation of glucocorticoid receptor signaling pathway [BP]
CG_h9_promoter_n_PM_12_252_9			2	0.5	2.52E-05	FOXP1	positive regulation of epithelial cell proliferation involved in lung morphogenesis [BP], positive regulation of immunoglobulin production [BP], positive regulation of cardiac muscle cell differentiation [BP], pre-B cell differentiation [BP], immunoglobulin V(D)J recombination [BP]
CG_h9_promoter_n_PM_14_9_6			1	0.25	5.80E-05	GP6	enzyme linked receptor protein signaling pathway [BP]
CG_h9_promoter_n_PM_16_50_26			1	0.25	6.70E-05	IGF2	receptor activator activity [MF]
CG_h9_promoter_n_PM_12_109_12			3	0.75	1.49E-04	TGFBR3, STX1A	myosin head/neck binding [MF], transforming growth factor beta receptor activity, type III [MF]
CG_h9_promoter_n_PM_14_74_11			2	0.5	4.44E-05	PPT1	protein depalmitoylation [BP], positive regulation of pinocytosis [BP], palmitoyl-(protein) hydrolase activity [MF]
CG_h9_promoter_n_PM_14_27_5			1	0.25	7.27E-05	AADAT, MAP4K1	2-aminoadipate transaminase activity [MF], MAP kinase kinase kinase kinase activity [MF]
CG_h9_promoter_n_PM_12_275_17			3	0.5	7.63E-05	ALDH3A1	alcohol dehydrogenase (NADP+) activity [MF]
CG_h9_promoter_n_PM_12_282_12			2	0.25	1.63E-04	CAMK2B, SEPT12, MEF2C	sinoatrial valve morphogenesis [BP], cellular response to trichostatin A [BP], spindle [CC], regulation of synaptic activity [BP], primary heart field specification [BP], sperm annulus [CC], inhibitory G-protein coupled receptor phosphorylation [BP]
CG_h9_promoter_n_PM_14_14_5			4	0.5	3.64E-05	GDE1, GSS	glutathione synthase activity [MF], glycerophosphoinositol glycerophosphodiesterase activity [MF]
CG_h9_promoter_n_PM_12_301_9			2	0.5	2.79E-05	SLC9A7, CHST1	keratan sulfotransferase activity [MF], potassium:hydrogen antiporter activity [MF]
CG_h9_promoter_n_PM_12_72_14			2	0.5	1.61E-04	LIF	positive regulation of histone H3-K27 acetylation [BP], RNA polymerase II transcription factor recruiting transcription factor activity [MF], positive regulation of protein localization to nucleus [BP], leukemia inhibitory factor receptor binding [MF]
CG_h9_promoter_n_PM_12_166_8			1	0.25	3.33E-04	CIZ1, MMS19, CYP24A1	25-hydroxycholecalciferol-24-hydroxylase activity [MF], 1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity [MF], maintenance of nucleus location [BP], phosphorelay signal transduction system [BP]
CG_h9_promoter_n_PM_12_159_4			1	0.25	6.77E-05	DDIT3, HPGD, OPRK1	lipoxygenase pathway [BP], dynorphin receptor activity [MF], negative regulation of determination of dorsal identity [BP]
CG_h9_promoter_n_PM_12_198_9			1	0.25	1.00E-04	ASTL, A4GALT	glutamic-type peptidase activity [MF], lactosylceramide 4-alpha-galactosyltransferase activity [MF], cortical granule [CC]
CG_h9_promoter_n_PM_16_42_22			1	0.25	1.51E-05	COQ3	2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [MF], 3-demethylubiquinone-9 3-O-methyltransferase activity [MF], hexaprenyldihydroxybenzoate methyltransferase activity [MF]
CG_h9_promoter_n_PM_12_310_13			3	0.5	8.92E-05	TRMT2B, IL10	negative regulation of chronic inflammatory response to antigenic stimulus [BP], negative regulation of interferon-alpha biosynthetic process [BP], interleukin-10 receptor binding [MF], negative regulation of myeloid dendritic cell activation [BP], S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [MF]
CG_h9_promoter_n_PM_12_179_10			1	0.25	5.96E-05	SUCLG1	succinate-CoA ligase complex (GDP-forming) [CC]
CG_h9_promoter_n_PM_14_78_21			3	0.75	1.49E-04	NACA, OAT	negative regulation of transcription from RNA polymerase II promoter involved in heart development [BP], positive regulation of skeletal muscle tissue growth [BP], ornithine-oxo-acid transaminase activity [MF], nascent polypeptide-associated complex [CC]
CG_h9_promoter_n_PM_12_157_4			2	0.5	2.61E-05	SRD5A2	sterol 5-alpha reductase activity [MF]
CG_h9_promoter_n_PM_12_162_7			2	0.5	2.78E-05	CELA1, IDH3G	pancreas morphogenesis [BP], isocitrate dehydrogenase (NAD+) activity [MF]
CG_h9_promoter_n_PM_14_30_14			2	0.5	2.37E-05	EPOR	erythropoietin receptor activity [MF]
CG_h9_promoter_n_PM_12_295_5			3	0.5	2.14E-04	GHRH	growth hormone-releasing hormone receptor binding [MF]
CG_h9_promoter_n_PM_12_42_9			3	0.5	9.78E-06	ADAM17, JHDM1D	histone H4-K20 demethylation [BP], histone demethylase activity (H4-K20 specific) [MF], histone H3-K27 demethylation [BP], histone demethylase activity (H3-K27 specific) [MF], response to high density lipoprotein particle stimulus [BP]
CG_h9_promoter_n_PM_12_95_7			2	0.5	2.69E-04	CITED1, SDC1	ureteric bud development [BP], myoblast development [BP], response to cAMP [BP], response to interleukin-9 [BP], response to interleukin-11 [BP]
CG_h9_promoter_n_PM_12_307_5			1	0.25	1.89E-05	MED13	androgen receptor signaling pathway [BP]
CG_h9_promoter_n_PM_16_27_36			1	0.25	3.18E-05	SLC46A1, SLC19A3	folic acid binding [MF]
CG_h9_promoter_n_PM_12_124_18			1	0.25	3.43E-05	MGAT4B, GCNT4	beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [MF], inter-male aggressive behavior [BP], N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [MF], alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [MF]
CG_h9_promoter_n_PM_12_201_12			2	0.5	1.63E-05	HEG1	lymph circulation [BP]
CG_h9_promoter_n_PM_14_46_16			2	0.5	9.20E-05	CLIP1, PPP1CC, E2F2, ANAPC1	mitotic cell cycle [BP]
CG_h9_promoter_n_PM_12_141_16			4	0.5	3.49E-05	PROP1	hypophysis morphogenesis [BP], canonical Wnt receptor signaling pathway [BP]
CG_h9_promoter_n_PM_12_114_7			1	0.25	1.83E-04	NTRK3	modulation by virus of host transcription [BP], positive regulation of axon extension involved in regeneration [BP]
CG_h9_promoter_n_PM_12_21_12			5	0.75	1.61E-05	FGFBP1, CCL23	negative regulation of cell proliferation [BP], negative regulation of C-C chemokine binding [BP]
CG_h9_promoter_n_PM_12_270_14			2	0.5	4.69E-05	SLC35B4	UDP-N-acetylglucosamine transmembrane transporter activity [MF], UDP-xylose transport [BP], UDP-N-acetylglucosamine transport [BP], UDP-xylose transmembrane transporter activity [MF]
CG_h9_promoter_n_PM_16_40_24			1	0.25	4.53E-05	CCBL1	L-phenylalanine:pyruvate aminotransferase activity [MF], L-phenylalanine-oxaloacetate transaminase activity [MF], glutamine-phenylpyruvate transaminase activity [MF], L-glutamine:pyruvate aminotransferase activity [MF]
CG_h9_promoter_n_PM_14_43_7			1	0.25	7.05E-05	SCIMP, GCH1	tetraspanin-enriched microdomain [CC], uropod membrane [CC], GTP cyclohydrolase I activity [MF], 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [BP]
CG_h9_promoter_n_PM_16_22_21			4	0.75	7.42E-05	NXF3, SRSF7	mRNA export from nucleus [BP]
CG_h9_promoter_n_PM_12_23_10			2	0.5	8.57E-05	PRHOXNB, GALE	UDP-glucose 4-epimerase activity [MF], purine nucleobase metabolic process [BP]
CG_h9_promoter_n_PM_16_48_12			1	0.25	4.32E-05	RETSAT, TK1, PDF	all-trans-retinol 13,14-reductase activity [MF], peptide deformylase activity [MF], fetal process involved in parturition [BP]
CG_h9_promoter_n_PM_12_228_4			2	0.5	7.58E-05	GALNS	N-acetylgalactosamine-6-sulfatase activity [MF]
CG_h9_promoter_n_PM_12_143_7			1	0.25	1.35E-04	OSM, PABPC1	oncostatin-M receptor binding [MF], negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [BP]
CG_h9_promoter_n_PM_14_34_16			1	0.25	2.88E-05	GPC3	peptidyl-dipeptidase inhibitor activity [MF]
CG_h9_promoter_n_PM_12_86_8			2	0.5	4.60E-05	ATE1	protein arginylation [BP], arginyltransferase activity [MF]
CG_h9_promoter_n_PM_16_16_15			1	0.25	1.65E-05	OXER1	5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF], 5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF], 5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF]
CG_h9_promoter_n_PM_12_74_13			2	0.5	2.07E-05	AP3D1, RAB43, DAB2	positive regulation of early endosome to late endosome transport [BP], clathrin adaptor activity [MF], positive regulation of integrin-mediated signaling pathway [BP], antigen processing and presentation, exogenous lipid antigen via MHC class Ib [BP], retrograde transport, plasma membrane to Golgi [BP], membrane coat [CC], synaptic vesicle membrane organization [BP]
CG_h9_promoter_n_PM_14_18_15			3	0.75	3.68E-05	TWF1	regulation of actin phosphorylation [BP]
CG_h9_promoter_n_PM_16_20_17			1	0.25	7.24E-05	RAB11FIP5	intracellular membrane-bounded organelle [CC]
CG_h9_promoter_n_PM_12_165_11			3	0.5	9.20E-05	ADAMTS8, MYO1F, CRK	low affinity phosphate transmembrane transporter activity [MF], regulation of actin cytoskeleton organization [BP]
CG_h9_promoter_n_PM_12_28_9			2	0.5	2.55E-05	AP1G1, CAMKK1, EIF4E, ENTHD2, NLRC4	eukaryotic initiation factor 4G binding [MF], cytosol [CC], pyroptosis [BP], IPAF inflammasome complex [CC]
CG_h9_promoter_n_PM_12_88_6			2	0.5	7.14E-06	IDH2	isocitrate dehydrogenase (NADP+) activity [MF], glyoxylate cycle [BP]
CG_h9_promoter_n_PM_12_267_3			1	0.25	1.97E-04	SLC35B4	UDP-xylose transport [BP], UDP-xylose transmembrane transporter activity [MF]
CG_h9_promoter_n_PM_12_18_7			1	0.25	5.01E-05	ABCB11	bile acid-exporting ATPase activity [MF], sodium-exporting ATPase activity, phosphorylative mechanism [MF], canalicular bile acid transmembrane transporter activity [MF]
CG_h9_promoter_n_PM_16_13_48			3	0.5	5.39E-05	HDDC3, RNF43	Wnt receptor catabolic process [BP], guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF]
CG_h9_promoter_n_PM_12_41_12			2	0.5	8.39E-05	ERCC3, TRPM7, AK2	sperm mitochondrial sheath [CC], nucleotide-excision repair, DNA duplex unwinding [BP], calcium-dependent cell-matrix adhesion [BP]
CG_h9_promoter_n_PM_12_244_7			1	0.25	1.52E-05	ABCC4	15-hydroxyprostaglandin dehydrogenase (NAD+) activity [MF]
CG_h9_promoter_n_PM_12_216_8			2	0.5	7.87E-05	FASN, PIF1	3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [MF], 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [MF], enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity [MF], [acyl-carrier-protein] S-acetyltransferase activity [MF], 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [MF], ATP-dependent 5'-3' DNA/RNA helicase activity [MF]
CG_h9_promoter_n_PM_12_176_6			1	0.25	2.54E-05	AIM2	positive regulation of cysteine-type endopeptidase activity [BP], pyroptosis [BP], AIM2 inflammasome complex [CC]
CG_h9_promoter_n_PM_12_345_11			1	0.25	1.08E-04	ARNT, SYNE4	integral to nuclear outer membrane [CC], aryl hydrocarbon receptor activity [MF]
CG_h9_promoter_n_PM_12_341_8			2	0.5	1.92E-04	CHCHD4	protein import into mitochondrial intermembrane space [BP]
CG_h9_promoter_n_PM_12_287_10			1	0.25	1.77E-04	ATXN3, JAK3	response to interleukin-9 [BP], negative regulation of FasL biosynthetic process [BP], negative regulation of dendritic cell cytokine production [BP], RNA polymerase II regulatory region DNA binding [MF]
CG_h9_promoter_n_PM_16_23_32			4	0.75	1.39E-05	GRM6	new growing cell tip [CC]
CG_h9_promoter_n_PM_12_269_11			2	0.5	1.25E-04	CYP2D6	negative regulation of cellular organofluorine metabolic process [BP]
CG_h9_promoter_n_PM_14_40_13			2	0.5	5.02E-05	VDR, NR0B2, UPF3B	steroid hormone receptor activity [MF], mRNA 3'-end processing [BP], vitamin D3 receptor activity [MF], retinoid X receptor binding [MF]
CG_h9_promoter_n_PM_16_31_7			1	0.25	5.36E-05	HLCS, PC	biotin binding [MF]
CG_h9_promoter_n_PM_12_83_6			1	0.25	7.46E-05	C22orf28, HPGD, TRMT6	tRNA processing [BP], lipoxygenase pathway [BP], RNA ligase (ATP) activity [MF]
CG_h9_promoter_n_PM_12_131_10			2	0.5	1.91E-04	TXNRD2	response to oxygen radical [BP]
CG_h9_promoter_n_PM_12_171_24			3	0.5	6.76E-06	GHRH	growth hormone-releasing hormone receptor binding [MF], growth hormone-releasing hormone activity [MF]
CG_h9_promoter_n_PM_14_75_7			2	0.5	6.95E-05	RASIP1, GDF2, VGF, ADAM8, PLXDC1, CECR1	angiogenesis [BP], positive regulation of neutrophil extravasation [BP], positive regulation of fibronectin-dependent thymocyte migration [BP], blood vessel morphogenesis [BP], dense core granule membrane [CC], alpha9-beta1 integrin-ADAM8 complex [CC], positive regulation of eosinophil migration [BP], growth factor activity [MF]
CG_h9_promoter_n_PM_16_36_11			1	0.25	9.59E-06	LOXL2, SHMT1, SEPHS2	glycine biosynthetic process from serine [BP], protein deamination [BP], selenocysteine biosynthetic process [BP]
CG_h9_promoter_n_PM_12_40_13			2	0.5	2.96E-05	ERCC3, COL7A1, AK2	collagen type VII [CC], nucleotide-excision repair, DNA duplex unwinding [BP], sperm mitochondrial sheath [CC]
CG_h9_promoter_n_PM_12_317_4			1	0.25	1.57E-04	RFX3	type B pancreatic cell maturation [BP], positive regulation of type B pancreatic cell development [BP]
CG_h9_promoter_n_PM_16_18_14			2	0.25	3.49E-05	OMD, ASNS, LSS, CREBBP, CYP39A1, HS3ST6	small molecule metabolic process [BP]
CG_h9_promoter_n_PM_12_178_9			2	0.5	2.44E-04	SNW1, PRKAA1, MOCS2	Mo-molybdopterin synthase activity [MF], SMAD3-SMAD4 protein complex [CC], molybdopterin synthase complex [CC], cold acclimation [BP], positive regulation of vitamin D receptor signaling pathway [BP], negative regulation of glucosylceramide biosynthetic process [BP]
CG_h9_promoter_n_PM_12_113_17			2	0.5	1.47E-04	KIAA0430, WIPI1, JUP, LSS, ABCB11	gamma-catenin-TCF7L2 complex [CC], canalicular bile acid transmembrane transporter activity [MF], bile acid-exporting ATPase activity [MF], vesicle targeting, trans-Golgi to endosome [BP], oogenesis [BP], lanosterol synthase activity [MF], structural constituent of cell wall [MF], sodium-exporting ATPase activity, phosphorylative mechanism [MF]
CG_h9_promoter_n_PM_12_75_6			2	0.5	6.25E-05	MPHOSPH6, EXOSC5	exosome (RNase complex) [CC]
CG_h9_promoter_n_PM_12_188_11			2	0.5	6.30E-05	APTX, STAU2, CHCHD4, TOPORS, INTS1	protein import into mitochondrial intermembrane space [BP], double-stranded RNA binding [MF], DNA topoisomerase binding [MF], DNA 5'-adenosine monophosphate hydrolase activity [MF], U2 snRNA 3'-end processing [BP]
CG_h9_promoter_n_PM_12_87_15			2	0.25	4.34E-05	CARS	cysteinyl-tRNA aminoacylation [BP], cysteine-tRNA ligase activity [MF]
CG_h9_promoter_n_PM_12_151_16			1	0.25	1.65E-04	KIAA1715, AGXT2L1, ADAM8, SHH	embryonic forelimb morphogenesis [BP], positive regulation of neutrophil extravasation [BP], embryonic digit morphogenesis [BP], mesenchymal smoothened signaling pathway involved in prostate gland development [BP], positive regulation of skeletal muscle cell proliferation [BP], ethanolamine-phosphate phospho-lyase activity [MF], positive regulation of fibronectin-dependent thymocyte migration [BP], regulation of mesenchymal cell proliferation involved in prostate gland development [BP], negative regulation of kidney smooth muscle cell differentiation [BP], multicellular structure septum development [BP], positive regulation of sclerotome development [BP], alpha9-beta1 integrin-ADAM8 complex [CC], negative regulation of ureter smooth muscle cell differentiation [BP], dense core granule membrane [CC], positive regulation of eosinophil migration [BP], positive regulation of ureter smooth muscle cell differentiation [BP], positive regulation of T cell differentiation in thymus [BP], positive regulation of kidney smooth muscle cell differentiation [BP]
CG_h9_promoter_n_PM_12_242_10			1	0.25	1.88E-05	SHARPIN	protein linear polyubiquitination [BP], LUBAC complex [CC], regulation of CD40 signaling pathway [BP]
CG_h9_promoter_n_PM_12_220_7			1	0.25	1.17E-04	LUZP1, SPTLC1, MYO5A	SPOTS complex [CC], neural fold bending [BP], endoplasmic reticulum localization [BP], sphinganine biosynthetic process [BP]
CG_h9_promoter_n_PM_12_209_13			2	0.25	1.89E-04	SMC1B, AGA, GRIN2C	directional locomotion [BP], protein deglycosylation [BP], N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [MF], nuclear meiotic cohesin complex [CC]
CG_h9_promoter_n_PM_12_97_4			1	0.25	1.46E-04	PDGFB, GK5, WARS, SUN2	negative regulation of phosphatidylinositol biosynthetic process [BP], nuclear migration along microfilament [BP], paracrine signaling [BP], metanephric glomerular endothelium development [BP], metanephric glomerular mesangial cell development [BP], cellular response to mycophenolic acid [BP], tryptophanyl-tRNA aminoacylation [BP], positive regulation of glomerular mesangial cell proliferation [BP], glycerol kinase activity [MF], tryptophan-tRNA ligase activity [MF]
CG_h9_promoter_n_PM_12_184_12			2	0.25	1.21E-05	GHRL, APOA2	response to estrogen stimulus [BP], negative regulation of cholesterol import [BP], growth hormone-releasing hormone activity [MF], positive regulation of cortisol secretion [BP], diacylglycerol catabolic process [BP], positive regulation of growth hormone receptor signaling pathway [BP], ghrelin receptor binding [MF], negative regulation of circadian sleep/wake cycle, REM sleep [BP], response to hormone stimulus [BP], positive regulation of circadian sleep/wake cycle, non-REM sleep [BP], negative regulation of cholesterol transporter activity [BP]
CG_h9_promoter_n_PM_12_5_10			2	0.5	1.85E-04	SLC5A6, STMN3	biotin metabolic process [BP], biotin transport [BP], negative regulation of Rac protein signal transduction [BP], regulation of microtubule polymerization or depolymerization [BP], pantothenate transmembrane transport [BP], sodium-dependent multivitamin transmembrane transporter activity [MF]
CG_h9_promoter_n_PM_12_296_17			3	0.75	1.01E-04	SIRT6	nuclear telomeric heterochromatin [CC]
CG_h9_promoter_n_PM_12_29_10			1	0.25	5.31E-05	BID, APOB, TREH	mature chylomicron [CC], alpha,alpha-trehalase activity [MF], glial cell apoptotic process [BP], chylomicron remnant [CC]
CG_h9_promoter_n_PM_12_79_8			2	0.5	1.59E-04	P2RY4, PPAT	UTP-activated nucleotide receptor activity [MF], amidophosphoribosyltransferase activity [MF]
CG_h9_promoter_n_PM_14_68_6			1	0.25	6.68E-05	NEK2, SEPP1	regulation of mitotic centrosome separation [BP], selenium compound metabolic process [BP]
CG_h9_promoter_n_PM_12_205_12			3	0.75	2.90E-04	ANXA11	cytokinesis, completion of separation [BP]
CG_h9_promoter_n_PM_12_160_9			1	0.25	1.62E-04	LSS, DNMT3A	S-adenosylhomocysteine metabolic process [BP], lanosterol synthase activity [MF], DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates [MF]
CG_h9_promoter_n_PM_12_195_10			1	0.25	1.66E-04	MITD1, AGXT2, ABCB6	heme-transporting ATPase activity [MF], L-alanine catabolic process, by transamination [BP], cytokinetic cell separation involved in cell cycle cytokinesis [BP], beta-alanine-pyruvate transaminase activity [MF], (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [MF]
CG_h9_promoter_n_PM_12_77_3			1	0.25	3.48E-05	LDHD	D-lactate dehydrogenase (cytochrome) activity [MF]
CG_h9_promoter_n_PM_16_35_4			1	0.25	3.27E-05	GRM4	presynaptic active zone membrane [CC]
CG_h9_promoter_n_PM_14_52_12			3	0.5	2.53E-05	HCAR2	nicotinic acid receptor activity [MF]
CG_h9_promoter_n_PM_12_36_13			2	0.5	1.42E-04	NTN4, APP	neuron remodeling [BP]
CG_h9_promoter_n_PM_12_11_6			3	0.75	1.13E-04	KLK14, CYB561	transmembrane electron transfer carrier [MF], seminal clot liquefaction [BP]
CG_h9_promoter_n_PM_12_258_4			1	0.25	2.06E-06	NPHS2, MPC1, FASTK	pyruvate transmembrane transporter activity [MF], Fas-activated serine/threonine kinase activity [MF], metanephric glomerular visceral epithelial cell development [BP], mitochondrial pyruvate transport [BP]
CG_h9_promoter_n_PM_14_60_9			2	0.5	3.96E-05	ATP6V1H, ATP6V1E1	transferrin transport [BP], proton-transporting ATPase activity, rotational mechanism [MF], ATP hydrolysis coupled proton transport [BP], proton-transporting two-sector ATPase complex, catalytic domain [CC]
CG_h9_promoter_n_PM_12_31_6			1	0.25	2.00E-05	SMPD4	sphingomyelin phosphodiesterase D activity [MF]
CG_h9_promoter_n_PM_14_57_23			3	0.75	5.96E-05	RBMX, ACTB	extracellular vesicular exosome [CC]
CG_h9_promoter_n_PM_12_129_4			1	0.25	2.55E-04	SEPT12, SLC35B1	UDP-galactose transmembrane transporter activity [MF], UDP-galactose transmembrane transport [BP], sperm annulus [CC]
CG_h9_promoter_n_PM_12_68_7			2	0.5	9.08E-05	LAMTOR1, ADAM8, TRIM5	positive regulation of tumor necrosis factor (ligand) superfamily member 11 production [BP], alpha9-beta1 integrin-ADAM8 complex [CC], positive regulation of neutrophil extravasation [BP], endosome localization [BP], positive regulation of fibronectin-dependent thymocyte migration [BP], activation of MAPK activity involved in innate immune response [BP], dense core granule membrane [CC], positive regulation of NF-kappaB transcription factor activity [BP], positive regulation of MAPK cascade [BP], positive regulation of eosinophil migration [BP]
CG_h9_promoter_n_PM_12_3_5			2	0.5	8.67E-05	CYP11A1, SERPINA7, C3AR1, LCT, ANGPT2, CXCL3	C3a anaphylatoxin receptor activity [MF], complement component C3a receptor activity [MF], response to corticosterone stimulus [BP], neutrophil chemotaxis [BP], cholesterol monooxygenase (side-chain-cleaving) activity [MF], lactase activity [MF], response to genistein [BP], leukocyte migration [BP], negative regulation of positive chemotaxis [BP], maternal process involved in female pregnancy [BP]
CG_h9_promoter_n_PM_12_356_11			2	0.5	1.24E-04	TGFB1	defense response to fungus, incompatible interaction [BP], negative regulation of hyaluronan biosynthetic process [BP], positive regulation of NAD+ ADP-ribosyltransferase activity [BP], positive regulation of protein import into nucleus [BP]
CG_h9_promoter_n_PM_12_298_6			2	0.5	9.88E-05	PTRF	rRNA primary transcript binding [MF]
CG_h9_promoter_n_PM_12_351_5			3	0.75	1.41E-04	ANPEP	metallopeptidase activity [MF]
CG_h9_promoter_n_PM_12_308_6			1	0.25	9.86E-05	C1QBP, GRIK5	complement component C1q binding [MF], negative regulation of RIG-I signaling pathway [BP], mitochondrial ribosome binding [MF], regulation of synaptic vesicle fusion to presynaptic membrane [BP], negative regulation of MDA-5 signaling pathway [BP], positive regulation of trophoblast cell migration [BP], kininogen binding [MF], positive regulation of mitochondrial translation [BP]
CG_h9_promoter_n_PM_14_8_20			3	0.75	3.73E-05	PIK3C2B	1-phosphatidylinositol-4-phosphate 3-kinase activity [MF]
CG_h9_promoter_n_PM_12_65_5			2	0.5	1.93E-05	NUMBL	neuroblast division in subventricular zone [BP]
CG_h9_promoter_n_PM_12_306_5			2	0.5	1.12E-04	IDE	beta-endorphin binding [MF], insulin catabolic process [BP]
CG_h9_promoter_n_PM_14_1_21			4	0.75	5.70E-05	MCM3, MCM6, FNIP1	MCM complex [CC], regulation of protein phosphorylation [BP]
CG_h9_promoter_n_PM_12_352_5			2	0.5	5.52E-05	TAT	L-tyrosine:2-oxoglutarate aminotransferase activity [MF]
CG_h9_promoter_n_PM_16_12_20			3	0.5	6.32E-05	AQP3, CXCL10	response to vitamin D [BP]
CG_h9_promoter_n_PM_12_204_6			1	0.25	5.03E-05	GLO1	lactoylglutathione lyase activity [MF]
CG_h9_promoter_n_PM_14_44_10			2	0.5	2.66E-05	EIF2B4, ACOT8, RPS14, RPL37	choloyl-CoA hydrolase activity [MF], translational initiation [BP]
CG_h9_promoter_n_PM_12_329_7			1	0.25	4.34E-04	CHCHD10	negative regulation of ATP citrate synthase activity [BP]
CG_h9_promoter_n_PM_16_3_76			1	0.25	5.94E-05	HRAS, PRKAR2A, PIK3C2A, MAPK1, AKT1S1, BCAR1, SOS1	epidermal growth factor receptor signaling pathway [BP], positive regulation of miRNA metabolic process [BP]
CG_h9_promoter_n_PM_12_163_7			1	0.25	8.72E-05	NCOR2	regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter [BP]
CG_h9_promoter_n_PM_12_232_7			1	0.25	8.30E-05	PRC1, AVP, DNASE2	mitotic spindle elongation [BP], neurohypophyseal hormone activity [MF], positive regulation of cellular pH reduction [BP], V1B vasopressin receptor binding [MF], V1A vasopressin receptor binding [MF], deoxyribonuclease II activity [MF]
CG_h9_promoter_n_PM_12_44_15			3	0.5	1.37E-04	UBE2S	protein K63-linked ubiquitination [BP]
CG_h9_promoter_n_PM_16_43_28			1	0.25	5.75E-05	VIPAS39, SIX1, TEFM, ZNF19, ZNF70, MNX1, PRDM14	regulation of transcription, DNA-dependent [BP]
CG_h9_promoter_n_PM_14_65_12			3	0.75	5.14E-05	PMVK, AQP7	phosphomevalonate kinase activity [MF], urea channel activity [MF]
CG_h9_promoter_n_PM_12_57_10			2	0.5	1.16E-04	ETV4	branching involved in mammary gland duct morphogenesis [BP]
CG_h9_promoter_n_PM_14_70_5			1	0.25	3.53E-05	BRF1, PRKAA1, GHSR	transcription factor TFIIIB complex [CC], negative regulation of glucosylceramide biosynthetic process [BP], cold acclimation [BP], growth hormone secretagogue receptor activity [MF]
CG_h9_promoter_n_PM_12_70_10			3	0.5	1.02E-05	CENPE, SLC17A5	sialic acid transmembrane transporter activity [MF], mitotic chromosome movement towards spindle pole [BP], sialic acid transport [BP]
CG_h9_promoter_n_PM_12_46_6			3	0.5	1.43E-04	CTSG, LPPR5	neutrophil mediated killing of gram-positive bacterium [BP], hydrolase activity [MF]
CG_h9_promoter_n_PM_12_64_23			1	0.25	8.67E-05	CYP8B1	7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity [MF], sterol 12-alpha-hydroxylase activity [MF]
CG_h9_promoter_n_PM_12_153_12			2	0.5	2.16E-04	ISYNA1	inositol-3-phosphate synthase activity [MF]
CG_h9_promoter_n_PM_14_47_8			1	0.25	4.62E-05	RPS6KA5, ZRANB3, OCSTAMP	DNA rewinding [BP], positive regulation of osteoclast proliferation [BP], histone H2A-S1 phosphorylation [BP]
CG_h9_promoter_n_PM_12_183_7			2	0.25	1.07E-04	CEP120	astral microtubule organization [BP]
CG_h9_promoter_n_PM_12_6_12			3	0.5	4.09E-05	CCBL1, LCT	L-glutamine:pyruvate aminotransferase activity [MF], lactase activity [MF], L-phenylalanine-oxaloacetate transaminase activity [MF], glutamine-phenylpyruvate transaminase activity [MF], L-phenylalanine:pyruvate aminotransferase activity [MF]
CG_h9_promoter_n_PM_12_80_6			2	0.5	2.20E-05	ALG2, NFS1	protein glycosylation in endoplasmic reticulum [BP], cysteine desulfurase activity [MF], iron incorporation into metallo-sulfur cluster [BP], GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [MF]
CG_h9_promoter_n_PM_12_71_6			1	0.25	1.15E-04	P2RX1	external side of cell outer membrane [CC]
CG_h9_promoter_n_PM_12_115_7			1	0.25	1.07E-04	TAF4, POLR2D	transcription elongation from RNA polymerase II promoter [BP]
CG_h9_promoter_n_PM_12_35_14			2	0.5	9.92E-05	CLPX, ANGPT2	mitochondrial endopeptidase Clp complex [CC], negative regulation of positive chemotaxis [BP]
CG_h9_promoter_n_PM_12_343_9			2	0.5	2.74E-05	DARS, RC3H1	aspartate-tRNA ligase activity [MF], negative regulation of germinal center formation [BP], aspartyl-tRNA aminoacylation [BP]
CG_h9_promoter_n_PM_12_297_7			3	0.75	6.72E-06	CALR3, TESK2, THEG	spermatogenesis [BP]
CG_h9_promoter_n_PM_12_185_7			1	0.25	4.08E-05	APOA2, MTNR1A	negative regulation of cholesterol import [BP], negative regulation of cholesterol transporter activity [BP], melatonin receptor activity [MF], diacylglycerol catabolic process [BP]
CG_h9_promoter_n_PM_12_312_8			1	0.25	4.32E-05	AADAT, TMEM86B, AIM2, KIF5B	alkenylglycerophosphoethanolamine hydrolase activity [MF], 2-aminoadipate transaminase activity [MF], pyroptosis [BP], alkenylglycerophosphocholine hydrolase activity [MF], stress granule disassembly [BP]
CG_h9_promoter_n_PM_12_104_16			1	0.25	3.36E-05	SLC26A1, DICER1, RACGAP1	sulfate transport [BP], spindle assembly [BP]
CG_h9_promoter_n_PM_12_172_5			1	0.25	2.04E-04	PLTP	vitamin E biosynthetic process [BP]
CG_h9_promoter_n_PM_12_76_4			2	0.5	1.26E-04	CHST6, CHST5	keratan sulfate metabolic process [BP], N-acetylglucosamine 6-O-sulfotransferase activity [MF], keratan sulfate biosynthetic process [BP], sulfotransferase activity [MF], N-acetylglucosamine metabolic process [BP]
CG_h9_promoter_n_PM_12_278_13			2	0.25	1.68E-04	DEFA1B	azurophil granule lumen [CC]
CG_h9_promoter_n_PM_12_313_8			1	0.25	4.04E-05	AP3D1	eye pigment biosynthetic process [BP], synaptic vesicle membrane organization [BP], antigen processing and presentation, exogenous lipid antigen via MHC class Ib [BP], positive regulation of NK T cell differentiation [BP]
CG_h9_promoter_n_PM_14_15_12			2	0.5	3.13E-05	BCL2, PTPRH	protein dephosphorylation [BP], negative regulation of cellular pH reduction [BP], CD8-positive, alpha-beta T cell lineage commitment [BP], positive regulation of neuron maturation [BP]
CG_h9_promoter_n_PM_12_142_22			4	0.5	6.84E-05	SYNCRIP, CLASP1, DDX23	catalytic step 2 spliceosome [CC], centrosomal corona [CC]
CG_h9_promoter_n_PM_14_19_7			1	0.25	6.17E-05	TCEB2, PSME4, MYO1C, PRKAA1, NDUFAF1, CDC26, UBE2H	protein K11-linked ubiquitination [BP], protein polyubiquitination [BP], positive regulation of vascular endothelial growth factor signaling pathway [BP], cold acclimation [BP], negative regulation of glucosylceramide biosynthetic process [BP], myosin I complex [CC], protein complex assembly [BP]
CG_h9_promoter_n_PM_12_318_9			2	0.5	1.10E-04	SLC6A3, IFNLR1, CRLF1, NSMF, IL22, IL15RA, TGFA	positive regulation of neuron migration [BP], cytokine receptor activity [MF], apical dendrite [CC], extracellular space [CC], dopamine:sodium symporter activity [MF], interleukin-22 receptor binding [MF], negative regulation of motor neuron apoptotic process [BP]
CG_h9_promoter_n_PM_12_346_9			2	0.5	9.41E-05	CASP1, WNT7B, SMNDC1	establishment or maintenance of polarity of embryonic epithelium [BP], induction of apoptosis [BP], outer medullary collecting duct development [BP]
CG_h9_promoter_n_PM_14_71_12			3	0.5	2.07E-05	CCBL1	L-phenylalanine:pyruvate aminotransferase activity [MF], L-phenylalanine-oxaloacetate transaminase activity [MF], glutamine-phenylpyruvate transaminase activity [MF], L-glutamine:pyruvate aminotransferase activity [MF], L-kynurenine catabolic process [BP]
CG_h9_promoter_n_PM_12_53_7			2	0.5	2.13E-04	COBL	actin filament network formation [BP]
CG_h9_promoter_n_PM_12_236_9			3	0.75	3.37E-05	ANGPT1, TRMT112	peptidyl-glutamine methylation [BP], regulation of satellite cell proliferation [BP]
CG_h9_promoter_n_PM_14_21_5			1	0.25	5.03E-05	MEX3D, TRPM7, AMACR	alpha-methylacyl-CoA racemase activity [MF], mRNA localization resulting in posttranscriptional regulation of gene expression [BP], calcium-dependent cell-matrix adhesion [BP]
CG_h9_promoter_n_PM_12_161_7			1	0.25	2.62E-04	SLC19A2	thiamine transmembrane transport [BP], thiamine transport [BP]
CG_h9_promoter_n_PM_12_251_7			1	0.25	1.61E-04	DUSP18, PTPN5, HSD17B11	androgen catabolic process [BP], protein dephosphorylation [BP], protein tyrosine phosphatase activity [MF]
CG_h9_promoter_n_PM_14_56_13			3	0.75	3.99E-05	DIMT1	18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [MF]
CG_h9_promoter_n_PM_16_41_14			3	0.75	3.77E-05	KDM5B, ST3GAL5	neolactotetraosylceramide alpha-2,3-sialyltransferase activity [MF], histone H3-K4 demethylation, trimethyl-H3-K4-specific [BP], histone demethylase activity (H3-trimethyl-K4 specific) [MF], lactosylceramide alpha-2,3-sialyltransferase activity [MF]
CG_h9_promoter_n_PM_12_152_9			1	0.25	4.20E-05	GAS6, MYH10	cellular response to vitamin K [BP], neuron migration [BP], negative regulation of protein import into nucleus, translocation [BP], negative regulation of interleukin-6 secretion [BP], negative regulation of renal albumin absorption [BP], negative regulation of oligodendrocyte apoptotic process [BP], hematopoietic stem cell migration to bone marrow [BP]
CG_h9_promoter_n_PM_12_30_10			1	0.25	1.23E-04	PRIMA1, CAMK2A, CHRNA10, SNCA, ITPK1	regulation of neurotransmitter secretion [BP], cell junction [CC], inositol-1,3,4-trisphosphate 6-kinase activity [MF], negative regulation of norepinephrine uptake [BP], inositol-1,3,4-trisphosphate 5-kinase activity [MF], negative regulation of dopamine uptake involved in synaptic transmission [BP], inositol tetrakisphosphate 1-kinase activity [MF], synapse [CC], synaptic transmission [BP], negative regulation of thrombin receptor signaling pathway [BP], regulation of neuronal synaptic plasticity [BP]
CG_h9_promoter_n_PM_12_7_9			2	0.5	1.45E-04	TP53, AHCTF1, WWTR1	negative regulation of helicase activity [BP], nuclear matrix [CC], oxidative stress-induced premature senescence [BP], transforming growth factor beta receptor signaling pathway [BP]
CG_h9_promoter_n_PM_12_240_7			1	0.25	1.92E-05	LPHN1, ADIPOR1, TNFRSF1A, C22orf28, ATP1A3, CTSH	RNA ligase (ATP) activity [MF], HLA-A specific activating MHC class I receptor activity [MF], hormone binding [MF], axon [CC]
CG_h9_promoter_n_PM_12_199_9			1	0.25	5.92E-05	SLC26A1	oxalate transmembrane transporter activity [MF]
CG_h9_promoter_n_PM_12_45_14			1	0.25	2.62E-04	DST, MOCS2	Mo-molybdopterin synthase activity [MF], molybdopterin synthase complex [CC], H zone [CC]
CG_h9_promoter_n_PM_12_302_8			3	0.5	1.41E-04	MBD3, WNT7B, C5	in utero embryonic development [BP]
CG_h9_promoter_n_PM_12_334_15			3	0.5	3.32E-05	UNC13D	granuloma formation [BP]
CG_h9_promoter_n_PM_12_354_12			2	0.5	2.57E-05	TGFB3, SLC13A1	sodium:sulfate symporter activity [MF], ossification involved in bone remodeling [BP], detection of hypoxia [BP]
CG_h9_promoter_n_PM_12_255_5			3	0.75	2.32E-04	APBB1, RERE	poly-glutamine tract binding [MF], negative regulation of thymidylate synthase biosynthetic process [BP]
CG_h9_promoter_n_PM_12_17_12			2	0.5	5.21E-05	MTOR, VCPIP1, MYBBP1A	regulation of carbohydrate utilization [BP], Golgi reassembly [BP], NLS-dependent protein nuclear import complex [CC], mTOR-FKBP12-rapamycin complex [CC]